Jeffrey Conroy
Amministratore Delegato presso Embody, Inc.
Profilo
Jeffrey Conroy is the Chairman & Chief Executive Officer and founder of Embody, Inc. which is founded in 2014.
He is currently an Independent Director at Cingulate Therapeutics LLC, Virginia Biosciences Health Research Corp., and Cingulate Works, Inc. He was formerly the Chairman of Virginia Biotechnology Association from 2014 to 2017.
He was also a Managing Director at Windward Investments LLC from 2012 to 2019 and Adjuvant Partners LLC from 2000 to 2012.
Additionally, he was the Head-Corporate Development at Específicos Stendhal SA de CV from 2012 to 2019.
He holds an undergraduate degree from Providence College.
Posizioni attive di Jeffrey Conroy
| Società | Posizione | Inizio |
|---|---|---|
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Direttore/Membro del Consiglio | 31/05/2018 |
Embody, Inc.
 Embody, Inc. Medical SpecialtiesHealth Technology Embody, Inc. designs, develops, and distributes implantable medical devices. The company was founded by Jeff Conroy and Michael Francis and is headquartered in Norfolk, VA. | Amministratore Delegato | 01/07/2015 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Direttore/Membro del Consiglio | 01/05/2018 |
| Virginia Biosciences Health Research Corp. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Jeffrey Conroy
| Società | Posizione | Fine |
|---|---|---|
| CINGULATE INC. | Direttore/Membro del Consiglio | 05/01/2023 |
| ODYSSEY HEALTH, INC. | Direttore/Membro del Consiglio | 04/01/2023 |
Windward Investments LLC
 Windward Investments LLC Financial ConglomeratesFinance Windward Investments LLC provides investment services. The company was founded in 2001 and is headquartered in Salt Lake City, UT. | Corporate Officer/Principal | 01/12/2019 |
Específicos Stendhal SA de CV
 Específicos Stendhal SA de CV Pharmaceuticals: MajorHealth Technology Part of Supernus Pharmaceuticals, Inc., Específicos Stendhal SA de CV is a Mexican company that manufactures pharmaceutical products. The company is based in DF. | Corporate Officer/Principal | 01/01/2019 |
Virginia Biotechnology Association
 Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Presidente | 30/08/2017 |
Formazione di Jeffrey Conroy
| Providence College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ODYSSEY HEALTH, INC. | Health Technology |
| CINGULATE INC. | Health Technology |
| Aziende private | 8 |
|---|---|
Virginia Biotechnology Association
Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Commercial Services |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Embody, Inc.
Embody, Inc. Medical SpecialtiesHealth Technology Embody, Inc. designs, develops, and distributes implantable medical devices. The company was founded by Jeff Conroy and Michael Francis and is headquartered in Norfolk, VA. | Health Technology |
Windward Investments LLC
Windward Investments LLC Financial ConglomeratesFinance Windward Investments LLC provides investment services. The company was founded in 2001 and is headquartered in Salt Lake City, UT. | Finance |
Específicos Stendhal SA de CV
Específicos Stendhal SA de CV Pharmaceuticals: MajorHealth Technology Part of Supernus Pharmaceuticals, Inc., Específicos Stendhal SA de CV is a Mexican company that manufactures pharmaceutical products. The company is based in DF. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
| Adjuvant Partners LLC | |
| Virginia Biosciences Health Research Corp. |
- Borsa valori
- Insiders
- Jeffrey Conroy
